Lv21
160 积分 2021-03-04 加入
《中国高尿酸血症与痛风诊疗指南(2019)》解读
9天前
已完结
Obinutuzumab is effective for the treatment of rituximab refractory PLA2R-associated membranous nephropathy
11天前
已完结
糖尿病肾脏病早期筛查与管理专家共识（2025版）
24天前
已完结
中国糖尿病肾脏病基层管理指南
26天前
已完结
Antigens in membranous nephropathy: discovery and clinical implications
1个月前
已完结
The epidemiology of IgA nephropathy: East versus West
2个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
2个月前
已完结
After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy
2个月前
已完结
Corticosteroids in IgA nephropathy: a randomised controlled trial
2个月前
已完结
皖公网安备34019202002308
